Literature DB >> 1924333

Induction of plasmacytomas secreting antigen-specific monoclonal antibodies with a retrovirus expressing v-abl and c-myc.

E M Weissinger1, H Mischak, D A Largaespada, D A Kaehler, T Mitchell, S J Smith-Gill, R Risser, J F Mushinski.   

Abstract

ABL-MYC, a recombinant murine retrovirus that expresses v-abl and c-myc, rapidly induces transplantable mono- or oligoclonal plasmacytomas in BALB/c mice. To determine if the targets for transformation of this retrovirus are antigen-committed B lymphocytes and to explore this system as an alternative technique for producing antigen-specific monoclonal antibodies, plasmacytomas were induced in mice that had been immunized with two different types of immunogens, hen egg white lysozyme and sheep red blood cells. The majority of these plasmacytomas secreted immunogen-specific antibodies. Plasmacytomas induced in unimmunized mice did not react with hen egg white lysozyme or sheep red blood cells. The specific antibodies were comparable in concentration, specificity, and affinity to monoclonal antibodies obtained with conventional hybridoma technology, but, in addition to IgGs and IgMs, they included specific IgA antibodies, which are rare among splenic-derived hybridomas. Our results demonstrate that a principal target for ABL-MYC is an antigen-committed B lymphocyte. In addition this procedure provides an alternative method for the production of monoclonal antibodies, without a requirement for hetero-caryon formation by cell fusion techniques.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1924333      PMCID: PMC52584          DOI: 10.1073/pnas.88.19.8735

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  23 in total

1.  Sequences of five potential recombination sites encoded close to an immunoglobulin kappa constant region gene.

Authors:  E E Max; J G Seidman; P Leder
Journal:  Proc Natl Acad Sci U S A       Date:  1979-07       Impact factor: 11.205

2.  The activity of an ABL-MYC retrovirus in fibroblast cell lines and in lymphocytes.

Authors:  D Largaespada; D Kaehler; E Weissinger; H Mischak; F Mushinski; R Risser
Journal:  Curr Top Microbiol Immunol       Date:  1990       Impact factor: 4.291

3.  Rapid viral induction of plasmacytomas in pristane-primed BALB-c mice.

Authors:  M Potter; M D Sklar; W P Rowe
Journal:  Science       Date:  1973-11-09       Impact factor: 47.728

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  The expressed lysozyme-specific B cell repertoire. I. Heterogeneity in the monoclonal anti-hen egg white lysozyme specificity repertoire, and its difference from the in situ repertoire.

Authors:  D W Metzger; L K Ch'ng; A Miller; E E Sercarz
Journal:  Eur J Immunol       Date:  1984-01       Impact factor: 5.532

6.  Structure of the Abelson murine leukemia virus genome and the homologous cellular gene: studies with cloned viral DNA.

Authors:  S P Goff; E Gilboa; O N Witte; D Baltimore
Journal:  Cell       Date:  1980-12       Impact factor: 41.582

7.  Particle concentration fluorescence immunoassay (PCFIA): a new, rapid immunoassay technique with high sensitivity.

Authors:  M E Jolley; C H Wang; S J Ekenberg; M S Zuelke; D M Kelso
Journal:  J Immunol Methods       Date:  1984-02-24       Impact factor: 2.303

8.  Translocation, breakage and truncated transcripts of c-myc oncogene in murine plasmacytomas.

Authors:  L W Stanton; R Watt; K B Marcu
Journal:  Nature       Date:  1983 Jun 2-8       Impact factor: 49.962

9.  Increased expression of myc-related oncogene mRNA characterizes most BALB/c plasmacytomas induced by pristane or Abelson murine leukemia virus.

Authors:  J F Mushinski; S R Bauer; M Potter; E P Reddy
Journal:  Proc Natl Acad Sci U S A       Date:  1983-02       Impact factor: 11.205

10.  Chromosomal translocations activating myc sequences and transduction of v-abl are critical events in the rapid induction of plasmacytomas by pristane and abelson virus.

Authors:  S Ohno; S Migita; F Wiener; M Babonits; G Klein; J F Mushinski; M Potter
Journal:  J Exp Med       Date:  1984-06-01       Impact factor: 14.307

View more
  5 in total

1.  Addition of constitutive c-myc expression to Abelson murine leukemia virus changes the phenotype of the cells transformed by the virus from pre-B-cell lymphomas to plasmacytomas.

Authors:  E M Weissinger; H Mischak; J Goodnight; W F Davidson; J F Mushinski
Journal:  Mol Cell Biol       Date:  1993-04       Impact factor: 4.272

2.  T cells induce terminal differentiation of transformed B cells to mature plasma cell tumors.

Authors:  D M Hilbert; M Y Shen; U R Rapp; S Rudikoff
Journal:  Proc Natl Acad Sci U S A       Date:  1995-01-31       Impact factor: 11.205

3.  Neutralization of bovine papillomavirus by antibodies to L1 and L2 capsid proteins.

Authors:  R B Roden; E M Weissinger; D W Henderson; F Booy; R Kirnbauer; J F Mushinski; D R Lowy; J T Schiller
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

4.  Skewed T-cell receptor Vbeta8.2 expression in transgenic CD2-myc induced thymic lymphoma: a role for antigen stimulation in tumour development?

Authors:  G Webster; D E Onions; J C Neil; E R Cameron
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

5.  Gene expression profiling reveals different pathways related to Abl and other genes that cooperate with c-Myc in a model of plasma cell neoplasia.

Authors:  Eun Sung Park; John D Shaughnessy; Shalu Gupta; Hongyang Wang; Ju-Seog Lee; Hyun Goo Woo; Fenghuang Zhan; James D Owens; Michael Potter; Siegfried Janz; J Frederic Mushinski
Journal:  BMC Genomics       Date:  2007-08-31       Impact factor: 3.969

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.